Gut Microbiome and Kidney Disease: a Bidirectional Relationship

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2016 May 1

PMID 27129691

Citations 81

Authors

Souhaila Al Khodor

Ibrahim F Shatat

Affiliations

Soon will be listed here.

Abstract

Recent technological advances and efforts, including powerful metagenomic and metatranscriptomic analyses, have led to a tremendous growth in our understanding of microbial communities. Changes in microbial abundance or composition of human microbial communities impact human health or disease state. However, explorations into the mechanisms underlying host-microbe interactions in health and disease are still in their infancy. Although changes in the gut microbiota have been described in patients with kidney disease, the relationships between pathogenesis, mechanisms of disease progression, and the gut microbiome are still evolving. Here, we review changes in the host-microbiome symbiotic relationship in an attempt to explore the bidirectional relationship in which alterations in the microbiome affect kidney disease progression and how kidney disease may disrupt a balanced microbiome. We also discuss potential targeted interventions that may help re-establish this symbiosis and propose more effective ways to deploy traditional treatments in patients with kidney disease.

Citing Articles

Animal Models for Studying Developmental Origins of Cardiovascular-Kidney-Metabolic Syndrome.

Tain Y, Lin Y, Hsu C Biomedicines. 2025; 13(2).

PMID: 40002865 PMC: 11853432. DOI: 10.3390/biomedicines13020452.

Investigation of a targeted panel of gut microbiome-derived toxins in children with chronic kidney disease.

Ebrahimi M, Hooper S, Mitsnefes M, Vasan R, Kimmel P, Warady B Pediatr Nephrol. 2025; .

PMID: 39820505 DOI: 10.1007/s00467-024-06580-6.

Is fruits granola beneficial for blood pressure management?.

Kundo N, Kitada K Hypertens Res. 2024; 48(1):439-441.

PMID: 39516369 DOI: 10.1038/s41440-024-01985-0.

Mechanisms of hepatic and renal injury in lipid metabolism disorders in metabolic syndrome.

Rong J, Zhang Z, Peng X, Li P, Zhao T, Zhong Y Int J Biol Sci. 2024; 20(12):4783-4798.

PMID: 39309427 PMC: 11414397. DOI: 10.7150/ijbs.100394.

Effect of fruits granola (Frugra®) consumption on blood pressure reduction and intestinal microbiome in patients undergoing hemodialysis.

Nagasawa H, Suzuki S, Kobayashi T, Otsuka T, Okuma T, Matsushita S Hypertens Res. 2024; 47(11):3214-3224.

PMID: 39300301 PMC: 11534689. DOI: 10.1038/s41440-024-01895-1.

References

Wu G, Chen J, Hoffmann C, Bittinger K, Chen Y, Keilbaugh S . Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011; 334(6052):105-8. PMC: 3368382. DOI: 10.1126/science.1208344. View

Akizawa T, Asano Y, Morita S, Wakita T, Onishi Y, Fukuhara S . Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. Am J Kidney Dis. 2009; 54(3):459-67. DOI: 10.1053/j.ajkd.2009.05.011. View

Missailidis C, Hallqvist J, Qureshi A, Barany P, Heimburger O, Lindholm B . Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease. PLoS One. 2016; 11(1):e0141738. PMC: 4709190. DOI: 10.1371/journal.pone.0141738. View

Schulman G, Agarwal R, Acharya M, Berl T, Blumenthal S, Kopyt N . A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120 (Kremezin) in patients with moderate to severe CKD. Am J Kidney Dis. 2006; 47(4):565-77. DOI: 10.1053/j.ajkd.2005.12.036. View

Wang I, Wu Y, Yang Y, Ting I, Lin C, Yen T . The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial. Benef Microbes. 2015; 6(4):423-30. DOI: 10.3920/BM2014.0088. View

Hamady M, Knight R . Microbial community profiling for human microbiome projects: Tools, techniques, and challenges. Genome Res. 2009; 19(7):1141-52. PMC: 3776646. DOI: 10.1101/gr.085464.108. View

Yang T, Santisteban M, Rodriguez V, Li E, Ahmari N, Carvajal J . Gut dysbiosis is linked to hypertension. Hypertension. 2015; 65(6):1331-40. PMC: 4433416. DOI: 10.1161/HYPERTENSIONAHA.115.05315. View

Al-Mosawi A . Acacia gum supplementation of a low-protein diet in children with end-stage renal disease. Pediatr Nephrol. 2004; 19(10):1156-9. DOI: 10.1007/s00467-004-1562-5. View

Dominguez-Bello M, Costello E, Contreras M, Magris M, Hidalgo G, Fierer N . Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A. 2010; 107(26):11971-5. PMC: 2900693. DOI: 10.1073/pnas.1002601107. View

10.

Major G, Spiller R . Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes. 2013; 21(1):15-21. PMC: 3871405. DOI: 10.1097/MED.0000000000000032. View

11.

Pflughoeft K, Versalovic J . Human microbiome in health and disease. Annu Rev Pathol. 2011; 7:99-122. DOI: 10.1146/annurev-pathol-011811-132421. View

12.

Morgan X, Huttenhower C . Chapter 12: Human microbiome analysis. PLoS Comput Biol. 2013; 8(12):e1002808. PMC: 3531975. DOI: 10.1371/journal.pcbi.1002808. View

13.

Koppe L, Mafra D, Fouque D . Probiotics and chronic kidney disease. Kidney Int. 2015; 88(5):958-66. DOI: 10.1038/ki.2015.255. View

14.

Pavan M . Influence of prebiotic and probiotic supplementation on the progression of chronic kidney disease. Minerva Urol Nefrol. 2014; 68(2):222-6. View

15.

Meijers B, Claes K, Bammens B, de Loor H, Viaene L, Verbeke K . p-Cresol and cardiovascular risk in mild-to-moderate kidney disease. Clin J Am Soc Nephrol. 2010; 5(7):1182-9. PMC: 2893077. DOI: 10.2215/CJN.07971109. View

16.

Falkner B . Hypertension in children and adolescents: epidemiology and natural history. Pediatr Nephrol. 2009; 25(7):1219-24. PMC: 2874036. DOI: 10.1007/s00467-009-1200-3. View

17.

Bliss D, Stein T, Schleifer C, Settle R . Supplementation with gum arabic fiber increases fecal nitrogen excretion and lowers serum urea nitrogen concentration in chronic renal failure patients consuming a low-protein diet. Am J Clin Nutr. 1996; 63(3):392-8. DOI: 10.1093/ajcn/63.3.392. View

18.

Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende D . Enterotypes of the human gut microbiome. Nature. 2011; 473(7346):174-80. PMC: 3728647. DOI: 10.1038/nature09944. View

19.

Jankowski J, van der Giet M, Jankowski V, Schmidt S, Hemeier M, Mahn B . Increased plasma phenylacetic acid in patients with end-stage renal failure inhibits iNOS expression. J Clin Invest. 2003; 112(2):256-64. PMC: 164281. DOI: 10.1172/JCI15524. View

20.

Rogers C, Prabhu K, Vijay-Kumar M . The microbiome and obesity-an established risk for certain types of cancer. Cancer J. 2014; 20(3):176-80. DOI: 10.1097/PPO.0000000000000049. View